Alzchem Group AG (XTER:ACT) Accounts Payable & Accrued Expense: €57.1 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:ACT Alzchem Group AG XTER:ACT
62 GF Score
Price €160.40
View Full Analysis

What is Alzchem Group AG Accounts Payable & Accrued Expense?

Alzchem Group AG XTER:ACT -2.31% 62 Accounts Payable & Accrued Expense is €57.1 Mil as of Jun. 2026. GuruFocus rates XTER:ACT with a GF Score™ of 62/100.

Alzchem Group AG's quarterly accounts payable & accrued expense declined from Dec. 2025 (€68.9 Mil) to Mar. 2026 (€0.0 Mil) but then increased from Mar. 2026 (€0.0 Mil) to Jun. 2026 (€57.1 Mil).

Alzchem Group AG's annual accounts payable & accrued expense increased from Dec. 2023 (€47.2 Mil) to Dec. 2024 (€57.3 Mil) and increased from Dec. 2024 (€57.3 Mil) to Dec. 2025 (€68.9 Mil).

Alzchem Group AG Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Alzchem Group AG's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzchem Group AG Accounts Payable & Accrued Expense Chart

Alzchem Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.64 45.47 47.23 57.27 68.94

Alzchem Group AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.23 0.00 68.94 0.00 57.07
XTER:ACT
62GF Score
Alzchem Group AG XTER:ACT
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzchem Group AG Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of €57.1 Mil mean?
Alzchem Group AG (XTER:ACT) has a Accounts Payable & Accrued Expense of €57.1 Mil as of Jun. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Alzchem Group AG and its competitors.
Is Alzchem Group AG's Accounts Payable & Accrued Expense too high?
Alzchem Group AG's current Accounts Payable & Accrued Expense is €57.1 Mil. Overall, Alzchem Group AG has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Accounts Payable & Accrued Expense compare to LIN and SHW?
Alzchem Group AG's Accounts Payable & Accrued Expense of €57.1 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Chemicals company?
A good Accounts Payable & Accrued Expense depends on the Chemicals industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Alzchem Group AG and its competitors. Alzchem Group AG's current Accounts Payable & Accrued Expense is €57.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (XTER:ACT) has a current Accounts Payable & Accrued Expense of €57.1 Mil. The current Accounts Payable & Accrued Expense is €57.1 Mil. Alzchem Group AG's overall GF Score™ is 62/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Alzchem Group AG (XTER:ACT), the current Accounts Payable & Accrued Expense is €57.1 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzchem Group AG Business Description

Address Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
62GF Score

Get the complete analysis for XTER:ACT

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€160.40
Price